DIAGNOSIS AND NOMENCLATURE OF THE DISORDERS OF THE TERMINAL PORTION OF THE ALDOSTERONE BIOSYNTHETIC PATHWAY.ULICK S.1976; J. CLIN. ENDOCRINOL. METABOL.; U.S.A.; DA. 1976; VOL. 43; NO 1; PP. 92-96; BIBL. 21 REF.Article

ADRENOCORTICAL FACTORS IN HYPERTENSION. I. SIGNIFICATION OF 18-HYDROXY-11-DEOXYCORTICOSTERONE.ULICK S.1976; AMER. J. CARDIOL.; U.S.A.; DA. 1976; VOL. 38; NO 6; PP. 814-824; BIBL. 2 P.Article

Two uncommon causes of mineralocorticoid excess : syndrome of apparent mineralocorticoid excess and glucocorticoid-remediable aldosteronismULICK, S.Endocrinology and metabolism clinics of North America. 1991, Vol 20, Num 2, pp 269-276, issn 0889-8529Article

ISOLATION AND IDENTIFICATION OF 18-HYDROXYCORTISOL FROM THE URINE OF PATIENTS WITH PRIMARY ALDOSTERONISMCHU MD; ULICK S.1982; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1982; VOL. 257; NO 5; PP. 2218-2224; BIBL. 32 REF.Article

ADRENOCORTICAL FACTORS IN HYPERTENSION. II. THE SIGNIFICANCE OF 16-OXYGENATED C-19 STEROIDS.ULICK S; RAMIREZ LC.1976; J. STEROID BIOCHEM.; G.B.; DA. 1976; VOL. 7; NO 11-12; PP. 953-961; BIBL. 43 REF.Article

DIFFERENCES IN ANTIPODAL SPECIFICITY IN THE BINDING OF STEROIDS TO SERUM PROTEINS = DIFFERENCES DANS LA SPECIFICITE ENANTIOMORPHE DE LA FIXATION DES STEROIDES SUR LES PROTEINES SERIQUESVARSANO AHARON N; ULICK S.1972; J. BIOL. CHEM.; U.S.A.; DA. 1972; VOL. 247; NO 16; PP. 4939-4943; BIBL. 38 REF.Article

ORALLY ACTIVE MINERALOCORTICOID AGONISTS AND ANTAGONISTS: DELTA ¹-DERIVATIVES OF ALDOSTERONE AND 18-DEOXYALDOSTERONEADAM WR; FUNDER JW; ULICK S et al.1981; ENDOCRINOLOGY (PHILADELPHIA); ISSN 0013-7227; USA; DA. 1981; VOL. 102; NO 2; PP. 517-521; BIBL. 21 REF.Article

FURTHER SIMPLIFICATIONS IN THE IMMUNOASSAY OF PLASMA ALDOSTERONE = NOUVELLES SIMPLIFICATIONS DANS LE DOSAGE IMMUNOLOGIQUE DE L'ALDOSTERONE PLASMATIQUEVARSANO AHARON N; ULICK S.1974; J. CLIN. ENDOCRINOL. METABOL.; U.S.A.; DA. 1974; VOL. 39; NO 2; PP. 375-379; BIBL. 12REF.Article

A PROTON MAGNETIC RESONANCE STUDY OF THE 18-HYDROXY DERIVATIVES OF CORTISOL AND CORTICOSTERONEARISON BH; CHU MD; ULICK S et al.1982; J. STEROID BIOCHEM.; ISSN 0022-4731; GBR; DA. 1982; VOL. 17; NO 5; PP. 467-469; BIBL. 10 REF.Article

STRUCTURE AND MECHANISM OF FORMATION OF THE TWO FORMS OF 18-HYDROXY-11 DEOXYCORTICOSTERONEROY AK; RAMIREZ LC; ULICK S et al.1976; J. STEROID BIOCHEM.; G.B.; DA. 1976; VOL. 7; NO 2; PP. 81-87; BIBL. 25 REF.Article

AN ABNORMALITY IN STEROID REDUCTIVE METABOLISM IN A HYPERSENSITIVE SYNDROME.ULICK S; RAMIREZ LC; NEW MI et al.1977; J. CLIN. ENDOCRINOL. METABOL.; U.S.A.; DA. 1977; VOL. 44; NO 4; PP. 799-802; BIBL. 5 REF.Article

MINERALOCORTICOID UNRESPONSIVENESS WITH SEVERE NEONATAL HYPONATREMIA AND HYPERKALEMIAROSENBERG S; FRANKS RC; ULICK S et al.1980; J. CLIN. ENDOCRINOL. METABOL.; USA; DA. 1980; VOL. 50; NO 2; PP. 401-404; BIBL. 19 REF.Article

MOLECULAR STRUCTURE OF 18-DEOXYALDOSTERONE AND ITS RELATIONSHIP TO RECEPTOR BINDING AND ACTIVITYDUAX WL; GRIFFIN JF; STRONG PD et al.1982; JOURNAL OF THE AMERICAN CHEMICAL SOCIETY; ISSN 0002-7863; USA; DA. 1982; VOL. 104; NO 25; PP. 7291-7293; BIBL. 15 REF.Article

Identification of a mineralocorticoid receptor binding substance in the urine of patients with congenital adrenal hyperplasiaLAND, M; ULICK, S.Journal of steroid biochemistry. 1987, Vol 26, Num 2, pp 207-211, issn 0022-4731Article

EVIDENCE FOR AN UNIDENTIFIED STEROID IN A CHILD WITH APPARENT MINERALOCORTICOID HYPERTENSION.NEW MI; LEVINE LS; BIGLIERI EG et al.1977; J. CLIN. ENDOCRINOL. METABOL.; U.S.A.; DA. 1977; VOL. 44; NO 5; PP. 924-933; BIBL. 27 REF.Article

Isolation and identification of an endogenous metabolite of 18-oxocortisol from human urineULICK, S; CHU, M. D.Journal of steroid biochemistry. 1987, Vol 28, Num 1, pp 89-94, issn 0022-4731Article

AMPLIFICATION OF THE ACTION OF ALDOSTERONE BY 5ALPHA -DIHYDROCORTISOLADAM WR; FUNDER JW; MERCER J et al.1978; ENDOCRINOLOGY; USA; DA. 1978; VOL. 103; NO 2; PP. 465-471; BIBL. 22 REF.Article

Anomalous oxidative cleavage of the side chain of 18-oxocortisol and its tetrahydro metaboliteCHAN, C. K; ULICK, S.Journal of steroid biochemistry. 1989, Vol 33, Num 4A, pp 605-611, issn 0022-4731, 7 p.Article

EVIDENCE FOR AN ALDOSTERONE BIOSYNTHETIC DEFECT IN CONGENITAL ADRENAL HYPERPLASIAULICK S; EBERLEIN WR; BLIFFELD AR et al.1980; J. CLIN. ENDOCRINOL. METAB.; ISSN 0021-972X; USA; DA. 1980; VOL. 51; NO 6; PP. 1346-1353; BIBL. 35 REF.Article

THE ETIOLOGY OF A SYNDROME OF FACTITIOUS MINERALOCORTICOID EXCESS: A STEROID-CONTAINING NASAL SPRAYFUNDER JW; ADAM WR; MANTERO F et al.1979; J. CLIN. ENDOCRINOL. METABOL.; USA; DA. 1979; VOL. 49; NO 6; PP. 842-846; BIBL. 14 REF.Article

THE NATURE OF THE DEFECT IN A SALT-WASTING DISORDER IN JEWS OF IRAN.ROSLER A; RABINOWITZ D; THEODOR R et al.1977; J. CLIN. ENDOCRINOL. METABOL.; U.S.A.; DA. 1977; VOL. 44; NO 2; PP. 279-291; BIBL. 2 P.Article

THE MINERALOCORTICOID ANTAGONIST ACTIVITY OF AN 11BETA ,18-OXIDOPREGNANEULICK S; MARVER D; ADAM WR et al.1979; ENDOCRINOLOGY; USA; DA. 1979; VOL. 104; NO 5; PP. 1352-1356; BIBL. 30 REF.Article

Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excessULICK, S; TEDDE, R; WANG, J. Z et al.The Journal of clinical endocrinology and metabolism. 1992, Vol 74, Num 3, pp 593-599, issn 0021-972XArticle

Evidence for cortisol as the mineralocorticoid in the syndrome of apparent mineralocorticoid excessTEDDE, R; PALA, A; MELIS, A et al.Journal of endocrinological investigation (Testo stampato). 1992, Vol 15, Num 6, pp 471-474, issn 0391-4097Article

Evidence for the secretion of an antimineralocorticoid in congenital adrenal hyperplasiaKUHNLE, U; LAND, M; ULICK, S et al.The Journal of clinical endocrinology and metabolism. 1986, Vol 62, Num 5, pp 934-940, issn 0021-972XArticle